
When people tell Dr. Dean Ornish they want to live longer, he asks them why. Maybe they want to dance at their kid’s wedding, they say, or finally write the book they’ve been thinking about for years. Whatever their answer, it gives them something to work toward and can make changing a habit today feel worth the effort.
Knowing what you want to stay healthy enough to do can shape the questions you ask at a doctor’s visit. It can also help you make sense of options like biological-age tests, peptides, and new uses for weight-loss drugs. At a TIME100 Talks panel in New York on Thursday titled “The Future of Men’s Health: From Reactive Treatment to Personalized Prevention,” three experts discussed how those goals can guide decisions about care.
What does that look like when a patient comes in with a specific complaint? TIME senior health correspondent Alice Park, who moderated the panel, asked how doctors could use that visit to talk about prevention. Dr. Anant Vinjamoori, chief medical officer of Hims & Hers—which sponsored the event—said the language doctors use often keeps the conversation focused on what’s wrong.
“We have terms like ‘history of present illness,’ ‘chief complaint,’ ‘problem list,’” Vinjamoori said. He suggested asking patients early in the visit what they hope to get out of their care. Their answer can help doctors figure out which preventive steps are worth talking through, he added.
To get ahead of age-related health problems, it would help to know when someone is aging faster than expected. Park asked Alan Cohen, who chairs biological complexity and healthy longevity at Columbia University, how researchers make that distinction. Even defining aging is tricky, he said. In a survey he helped lead, scientists who study aging disagreed on what it is, when it begins, and whether it can be measured.
“I think health is actually an easier target to measure than aging,” Cohen said. A biological-age test can be good at estimating how old you are, he explained, while leaving some of the questions that matter most in daily life unanswered. “Are you able to be and do the things that matter to you?” he asked. A clinician might measure how well someone walks, he said. He’d also want to know whether that person can get to the store.
Park asked about peptides, which some people are trying on their own in hopes of improving their health. “There’s not a peptide or compound that everyone here should be on,” Vinjamoori said. He suggested talking with a clinician and raised concerns about the quality of products sold as “research use only.” The U.S. Food and Drug Administration has flagged potential safety risks with compounded BPC-157, saying it has too little information to determine whether it could harm people.
The evidence is stronger for some peptides than for others. Ornish, founder and president of the Preventive Medicine Research Institute, said he sees GLP-1 drugs as a possible “jumpstart” that can help people feel well enough to make changes they can stick with. He pointed to a large clinical trial that enrolled adults with established cardiovascular disease and a BMI in the overweight or obesity range. The trial excluded people with diabetes. Compared with a placebo, those taking semaglutide experienced a lowered relative risk of heart attack, stroke, or cardiovascular death.
When Park asked where someone who feels overwhelmed by health advice should start, Ornish suggested picking something you can do even on a busy day. “If I don’t have time to meditate for an hour, do it for a minute,” he said. If a half-hour walk is out of reach, he suggested walking around the room while you’re on the phone. “I think the consistency is more important than anything else.”
TIME100 Talk: The Future of Men's Health: From Personalized Treatment to Reactive Care was presented by Hims.